Filing Flows › Companies › Alignment Healthcare › Timeline
Alignment Healthcare stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions−55.5% to $7.34
Alignment Healthcare (ALHC) stock fell 56% over the last 252 sessions, to $7.34. On the way it reported 4 quarters, its insiders filed 14 open-market trades and 10 Form 144 notices of planned sales, and the company filed 1 material 8-K. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Oct 29, 2026 | Earnings | Earnings: beat the EPS estimate by 5.9% | −1.5% (−1.1% vs SPY) | −0.5% (+0.2% vs SPY) | — |
| Oct 6, 2026 | Form 144 | Form 144: Hyong (Ken) Kim, M.D. plans to sell $305K | −1.5% (−2.1% vs SPY) | −4.9% (−5.4% vs SPY) | −14.0% (−11.3% vs SPY) |
| Sep 17, 2026 | Form 144 | Form 144: Joseph Konowiecki plans to sell $226K | −0.1% (−1.2% vs SPY) | −10.3% (−12.3% vs SPY) | −6.7% (−9.2% vs SPY) |
| Sep 17, 2026 | Insider sale | Konowiecki Joseph S sold $202K | −0.1% (−1.2% vs SPY) | −10.3% (−12.3% vs SPY) | −6.7% (−9.2% vs SPY) |
| Sep 11, 2026 | Insider sale | Maroney Dawn Christine sold $1.6M | −1.2% (−2.0% vs SPY) | −38.3% (−38.9% vs SPY) | −52.5% (−55.5% vs SPY) |
| Sep 10, 2026 | Form 144 | Form 144: John Kao plans to sell $5.3M | −2.1% (−1.5% vs SPY) | −40.3% (−39.2% vs SPY) | −40.3% (−42.0% vs SPY) |
| Sep 10, 2026 | Form 144 | Form 144: Dawn C. Maroney plans to sell $1.7M | −2.1% (−1.5% vs SPY) | −40.3% (−39.2% vs SPY) | −40.3% (−42.0% vs SPY) |
| Sep 10, 2026 | Form 144 | Form 144: JEK Trust U/A DTD 02/08/2021 plans to sell $6.5M | −2.1% (−1.5% vs SPY) | −40.3% (−39.2% vs SPY) | −40.3% (−42.0% vs SPY) |
| Aug 14, 2026 | Form 144 | Form 144: Dawn Maroney plans to sell $67K | +3.7% (+3.8% vs SPY) | −4.0% (−2.0% vs SPY) | −3.9% (−1.7% vs SPY) |
| Jul 30, 2026 | Earnings | Earnings: beat the EPS estimate by 24.3% | +1.7% (+0.1% vs SPY) | −29.0% (−34.4% vs SPY) | −29.9% (−35.5% vs SPY) |
| Jul 15, 2026 | Form 144 | Form 144: Dawn Maroney plans to sell $3.8M | −1.3% (−1.7% vs SPY) | +1.4% (+1.9% vs SPY) | −45.0% (−47.7% vs SPY) |
| Jul 10, 2026 | Form 144 | Form 144: JEK Trust U/A DTD 02/08/2021 plans to sell $12.5M | −5.9% (−6.3% vs SPY) | −4.9% (−4.8% vs SPY) | −38.1% (−40.9% vs SPY) |
| Jul 1, 2026 | Form 144 | Form 144: Joseph Konowiecki plans to sell $600K | +0.8% (+1.0% vs SPY) | −17.3% (−17.1% vs SPY) | −24.6% (−24.0% vs SPY) |
| Jun 26, 2026 | Form 144 | Form 144: Joseph Konowiecki plans to sell $575K | +2.1% (+2.8% vs SPY) | +4.7% (+3.3% vs SPY) | −19.6% (−20.2% vs SPY) |
| Jun 2, 2026 | Insider buy | Kent Mark D. bought $198K | +2.5% (+2.4% vs SPY) | +14.3% (+16.9% vs SPY) | +59.1% (+60.5% vs SPY) |
| Apr 30, 2026 | Earnings | Earnings: beat the EPS estimate by 38.7% | +3.7% (+2.7% vs SPY) | −18.0% (−21.1% vs SPY) | −34.9% (−41.0% vs SPY) |
| Apr 7, 2026 | Insider sale | Head James M sold $234K | +14.9% (+14.8% vs SPY) | +11.7% (+7.6% vs SPY) | −2.0% (−11.4% vs SPY) |
| Mar 18, 2026 | Insider sale | Scavo Robert L. sold $201K | +1.5% (+2.9% vs SPY) | −2.8% (−0.4% vs SPY) | +15.0% (+10.2% vs SPY) |
| Mar 18, 2026 | Insider sale | Maroney Dawn Christine sold $656K | +1.5% (+2.9% vs SPY) | −2.8% (−0.4% vs SPY) | +15.0% (+10.2% vs SPY) |
| Mar 18, 2026 | Insider sale | Kim Hyong sold $328K | +1.5% (+2.9% vs SPY) | −2.8% (−0.4% vs SPY) | +15.0% (+10.2% vs SPY) |
| Mar 18, 2026 | Insider sale | Kao John E sold $1.3M | +1.5% (+2.9% vs SPY) | −2.8% (−0.4% vs SPY) | +15.0% (+10.2% vs SPY) |
| Mar 18, 2026 | Insider sale | Joyce Christopher J sold $448K | +1.5% (+2.9% vs SPY) | −2.8% (−0.4% vs SPY) | +15.0% (+10.2% vs SPY) |
| Mar 18, 2026 | Insider sale | Burzacchi Sebastian sold $274K | +1.5% (+2.9% vs SPY) | −2.8% (−0.4% vs SPY) | +15.0% (+10.2% vs SPY) |
| Mar 12, 2026 | Insider sale | Scavo Robert L. sold $71K | −5.1% (−3.5% vs SPY) | +1.0% (+3.2% vs SPY) | +12.9% (+12.2% vs SPY) |
| Mar 12, 2026 | Insider sale | Maroney Dawn Christine sold $508K | −5.1% (−3.5% vs SPY) | +1.0% (+3.2% vs SPY) | +12.9% (+12.2% vs SPY) |
| Mar 12, 2026 | Insider sale | Kao John E sold $853K | −5.1% (−3.5% vs SPY) | +1.0% (+3.2% vs SPY) | +12.9% (+12.2% vs SPY) |
| Mar 4, 2026 | 8-K | Material definitive agreement | −1.7% (−1.1% vs SPY) | −4.7% (−3.4% vs SPY) | −0.7% (+3.4% vs SPY) |
| Feb 26, 2026 | Earnings | Earnings: beat the EPS estimate by 98.2% | +1.4% (+2.0% vs SPY) | −6.4% (−5.3% vs SPY) | −17.5% (−10.5% vs SPY) |
| Feb 10, 2026 | Insider sale | Wagner Andreas P. sold $455K | −0.6% (−0.4% vs SPY) | −0.8% (+0.8% vs SPY) | −14.2% (−11.6% vs SPY) |
Insiders’ record here
In the year on the chart, Alignment Healthcare's insiders reported 1 open-market buy ($198K) and 13 sales ($7.1M). Of the 12 old enough to score, 2 were followed by the stock doing what the trade implied over the next 63 sessions (beating SPY after a buy, lagging it after a sale); the median excess return after a buy was −0.7% and after a sale +5.7%.
Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 1.01 Material definitive agreement | 23,525 | 0.0% | 51% | +1.0% | ±1.4% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
Report card: every quarter against the estimate → Alignment Healthcare: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.